Kura Oncology, Inc.
KURANasdaqCIK 1422143HealthcareFiscal year ends Dec 31
Reports and events: 238 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0907:05 ET | 8-K | 8.01 Other events | 0001193125-26-385881 |
| 2026-09-0807:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-384363 |
| 2026-08-1216:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-346884 |
| 2026-08-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346856 |
| 2026-07-2917:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-324202 |
| 2026-06-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257368 |
| 2026-05-1216:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219481 |
| 2026-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219422 |
| 2026-04-1016:25 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-151335 |
| 2026-03-0507:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-092567 |
| 2026-03-0506:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092465 |
| 2026-01-2917:25 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-029705 |
| 2026-01-1206:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009649 |
| 2025-12-0208:10 ET | 8-K | 8.01 Other events | 0001193125-25-304559 |
| 2025-11-1316:27 ET | 8-K | 8.01 Other events | 0001193125-25-280255 |
| 2025-11-0407:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-263589 |
| 2025-11-0406:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263491 |
| 2025-10-2407:24 ET | 8-K | 8.01 Other events | 0001193125-25-249348 |
| 2025-10-1616:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241416 |
| 2025-08-0716:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105051 |
| 2025-08-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105024 |
| 2025-07-0106:09 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-153393 |
| 2025-06-1817:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-142816 |
| 2025-06-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-083046 |
| 2025-06-0306:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-133717 |
| 2025-05-0116:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-061848 |
| 2025-05-0116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061836 |
| 2025-04-1116:50 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0000950170-25-053335 |
| 2025-02-2816:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029975 |
| 2025-02-2616:05 ET | 8-K | 2.02 Results of operations | 0000950170-25-027706 |
| 2025-02-0516:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-020831 |
| 2025-01-1416:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-006197 |
| 2025-01-0616:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-25-002189 |
| 2024-12-2016:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-283109 |
| 2024-11-2017:21 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-262641 |
| 2024-11-0716:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123363 |
| 2024-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123321 |
| 2024-09-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-220529 |
| 2024-08-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093997 |
| 2024-08-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093945 |
| 2024-06-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070584 |
| 2024-05-2416:06 ET | 8-K | 8.01 Other events | 0001193125-24-147030 |
| 2024-05-0216:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052136 |
| 2024-05-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052109 |
| 2024-04-1216:26 ET | DEF 14A | Proxy statementPeriod 2024-04-12 | 0000950170-24-044066 |
| 2024-02-2716:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021094 |
| 2024-02-2716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021087 |
| 2024-01-3007:08 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-018713 |
| 2024-01-2616:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-016715 |
| 2023-12-2209:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-301830 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.